BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 3414330)

  • 1. Termination of second trimester pregnancy with laminaria and intramuscular 16 phenoxy-omega-17, 18, 19, 20 tetranor PGE2 methylsulfonylamide (sulprostone)-A randomised study.
    Karim SM; Ratnam SS; Lim AL; Yeo KC; Choo HT
    Prostaglandins; 1982 Feb; 23(2):257-63. PubMed ID: 7043657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphologic and biochemical aspects of prostaglandin-induced cervix ripening].
    Rath W; Adelmann-Grill BC; Schauer A; Kuhn W
    Z Geburtshilfe Perinatol; 1987; 191(1):21-8. PubMed ID: 3554798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
    Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
    Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preoperative cervical dilatation in abortion during the 1st trimester with sulprostone].
    Schulz BO; Gethmann U; Lehmann F
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):185-7. PubMed ID: 6562984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphological characteristics and ultrastructural aspects of cervical ripening induced by sulprostone.
    Di Lieto A; Catalano D; Campanile M; Negri R; Albano G; Dell'Isola A; Paladini A; Orlandi GR
    Acta Eur Fertil; 1988; 19(1):33-6. PubMed ID: 3414330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles of physiologic and drug-induced cervix ripening--recent morphologic and biochemical findings].
    Rath W; Osmers R; Adelmann-Grill BC; Stuhlsatz HW; Tschesche H; Szevérini M
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):657-64. PubMed ID: 2272430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiology of cervical ripening and cervical dilatation and the effect of abortifacient drugs.
    Uldbjerg N; Ulmsten U
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):263-82. PubMed ID: 2225599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and biological control of cervical function.
    Calder AA
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):347-51. PubMed ID: 7848214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ripening of the human uterine cervix in terms of connective tissue biochemistry.
    Uldbjerg N; Ulmsten U; Ekman G
    Clin Obstet Gynecol; 1983 Mar; 26(1):14-26. PubMed ID: 6340890
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.